Medical Care
Global Oncology Blood Testing Market Research Report 2025
- Jul 08, 25
- ID: 347910
- Pages: 78
- Figures: 72
- Views: 1
The global market for Oncology Blood Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Oncology Blood Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Blood Testing.
The Oncology Blood Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Blood Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Blood Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Segment by Type
Blood Protein Testing
Tumor Marker Testing
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Blood Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Oncology blood testing is a revolutionary diagnostic technique to detect cancer in early stages. For early detection of cancer, liquid biopsies have become a popular diagnostic tool.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Oncology Blood Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Blood Testing.
The Oncology Blood Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Blood Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Blood Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Segment by Type
Blood Protein Testing
Tumor Marker Testing
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Blood Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Blood Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Blood Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Blood Testing Market Perspective (2020-2031)
2.2 Global Oncology Blood Testing Growth Trends by Region
2.2.1 Global Oncology Blood Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Blood Testing Historic Market Size by Region (2020-2025)
2.2.3 Oncology Blood Testing Forecasted Market Size by Region (2026-2031)
2.3 Oncology Blood Testing Market Dynamics
2.3.1 Oncology Blood Testing Industry Trends
2.3.2 Oncology Blood Testing Market Drivers
2.3.3 Oncology Blood Testing Market Challenges
2.3.4 Oncology Blood Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Blood Testing Players by Revenue
3.1.1 Global Top Oncology Blood Testing Players by Revenue (2020-2025)
3.1.2 Global Oncology Blood Testing Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Blood Testing Revenue
3.4 Global Oncology Blood Testing Market Concentration Ratio
3.4.1 Global Oncology Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Blood Testing Revenue in 2024
3.5 Global Key Players of Oncology Blood Testing Head office and Area Served
3.6 Global Key Players of Oncology Blood Testing, Product and Application
3.7 Global Key Players of Oncology Blood Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Blood Testing Breakdown Data by Type
4.1 Global Oncology Blood Testing Historic Market Size by Type (2020-2025)
4.2 Global Oncology Blood Testing Forecasted Market Size by Type (2026-2031)
5 Oncology Blood Testing Breakdown Data by Application
5.1 Global Oncology Blood Testing Historic Market Size by Application (2020-2025)
5.2 Global Oncology Blood Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Blood Testing Market Size (2020-2031)
6.2 North America Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Blood Testing Market Size by Country (2020-2025)
6.4 North America Oncology Blood Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Blood Testing Market Size (2020-2031)
7.2 Europe Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Blood Testing Market Size by Country (2020-2025)
7.4 Europe Oncology Blood Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Blood Testing Market Size (2020-2031)
8.2 Asia-Pacific Oncology Blood Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Blood Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Blood Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Blood Testing Market Size (2020-2031)
9.2 Latin America Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Blood Testing Market Size by Country (2020-2025)
9.4 Latin America Oncology Blood Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Blood Testing Market Size (2020-2031)
10.2 Middle East & Africa Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Blood Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Blood Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Details
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Oncology Blood Testing Introduction
11.1.4 Guardant Health Revenue in Oncology Blood Testing Business (2020-2025)
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Details
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Oncology Blood Testing Introduction
11.2.4 Trovagene Revenue in Oncology Blood Testing Business (2020-2025)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Oncology Blood Testing Introduction
11.3.4 Genomic Health Revenue in Oncology Blood Testing Business (2020-2025)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oncology Blood Testing Introduction
11.4.4 Roche Revenue in Oncology Blood Testing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Details
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Oncology Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Oncology Blood Testing Business (2020-2025)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Details
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Oncology Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Oncology Blood Testing Business (2020-2025)
11.6.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Blood Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Blood Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Blood Testing Market Perspective (2020-2031)
2.2 Global Oncology Blood Testing Growth Trends by Region
2.2.1 Global Oncology Blood Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Blood Testing Historic Market Size by Region (2020-2025)
2.2.3 Oncology Blood Testing Forecasted Market Size by Region (2026-2031)
2.3 Oncology Blood Testing Market Dynamics
2.3.1 Oncology Blood Testing Industry Trends
2.3.2 Oncology Blood Testing Market Drivers
2.3.3 Oncology Blood Testing Market Challenges
2.3.4 Oncology Blood Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Blood Testing Players by Revenue
3.1.1 Global Top Oncology Blood Testing Players by Revenue (2020-2025)
3.1.2 Global Oncology Blood Testing Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Blood Testing Revenue
3.4 Global Oncology Blood Testing Market Concentration Ratio
3.4.1 Global Oncology Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Blood Testing Revenue in 2024
3.5 Global Key Players of Oncology Blood Testing Head office and Area Served
3.6 Global Key Players of Oncology Blood Testing, Product and Application
3.7 Global Key Players of Oncology Blood Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Blood Testing Breakdown Data by Type
4.1 Global Oncology Blood Testing Historic Market Size by Type (2020-2025)
4.2 Global Oncology Blood Testing Forecasted Market Size by Type (2026-2031)
5 Oncology Blood Testing Breakdown Data by Application
5.1 Global Oncology Blood Testing Historic Market Size by Application (2020-2025)
5.2 Global Oncology Blood Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Blood Testing Market Size (2020-2031)
6.2 North America Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Blood Testing Market Size by Country (2020-2025)
6.4 North America Oncology Blood Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Blood Testing Market Size (2020-2031)
7.2 Europe Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Blood Testing Market Size by Country (2020-2025)
7.4 Europe Oncology Blood Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Blood Testing Market Size (2020-2031)
8.2 Asia-Pacific Oncology Blood Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Blood Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Blood Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Blood Testing Market Size (2020-2031)
9.2 Latin America Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Blood Testing Market Size by Country (2020-2025)
9.4 Latin America Oncology Blood Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Blood Testing Market Size (2020-2031)
10.2 Middle East & Africa Oncology Blood Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Blood Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Blood Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Details
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Oncology Blood Testing Introduction
11.1.4 Guardant Health Revenue in Oncology Blood Testing Business (2020-2025)
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Details
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Oncology Blood Testing Introduction
11.2.4 Trovagene Revenue in Oncology Blood Testing Business (2020-2025)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Oncology Blood Testing Introduction
11.3.4 Genomic Health Revenue in Oncology Blood Testing Business (2020-2025)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oncology Blood Testing Introduction
11.4.4 Roche Revenue in Oncology Blood Testing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Details
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Oncology Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Oncology Blood Testing Business (2020-2025)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Details
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Oncology Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Oncology Blood Testing Business (2020-2025)
11.6.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncology Blood Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Protein Testing
Table 3. Key Players of Tumor Marker Testing
Table 4. Key Players of Others
Table 5. Global Oncology Blood Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oncology Blood Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oncology Blood Testing Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Oncology Blood Testing Market Share by Region (2020-2025)
Table 9. Global Oncology Blood Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Oncology Blood Testing Market Share by Region (2026-2031)
Table 11. Oncology Blood Testing Market Trends
Table 12. Oncology Blood Testing Market Drivers
Table 13. Oncology Blood Testing Market Challenges
Table 14. Oncology Blood Testing Market Restraints
Table 15. Global Oncology Blood Testing Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Oncology Blood Testing Market Share by Players (2020-2025)
Table 17. Global Top Oncology Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Blood Testing as of 2024)
Table 18. Ranking of Global Top Oncology Blood Testing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oncology Blood Testing Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Oncology Blood Testing, Headquarters and Area Served
Table 21. Global Key Players of Oncology Blood Testing, Product and Application
Table 22. Global Key Players of Oncology Blood Testing, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Blood Testing Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Oncology Blood Testing Revenue Market Share by Type (2020-2025)
Table 26. Global Oncology Blood Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Oncology Blood Testing Revenue Market Share by Type (2026-2031)
Table 28. Global Oncology Blood Testing Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Oncology Blood Testing Revenue Market Share by Application (2020-2025)
Table 30. Global Oncology Blood Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Oncology Blood Testing Revenue Market Share by Application (2026-2031)
Table 32. North America Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Oncology Blood Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Oncology Blood Testing Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oncology Blood Testing Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Guardant Health Company Details
Table 48. Guardant Health Business Overview
Table 49. Guardant Health Oncology Blood Testing Product
Table 50. Guardant Health Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 51. Guardant Health Recent Development
Table 52. Trovagene Company Details
Table 53. Trovagene Business Overview
Table 54. Trovagene Oncology Blood Testing Product
Table 55. Trovagene Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 56. Trovagene Recent Development
Table 57. Genomic Health Company Details
Table 58. Genomic Health Business Overview
Table 59. Genomic Health Oncology Blood Testing Product
Table 60. Genomic Health Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 61. Genomic Health Recent Development
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Oncology Blood Testing Product
Table 65. Roche Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Bio-Techne Company Details
Table 68. Bio-Techne Business Overview
Table 69. Bio-Techne Oncology Blood Testing Product
Table 70. Bio-Techne Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 71. Bio-Techne Recent Development
Table 72. Pathway Genomics Company Details
Table 73. Pathway Genomics Business Overview
Table 74. Pathway Genomics Oncology Blood Testing Product
Table 75. Pathway Genomics Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 76. Pathway Genomics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Oncology Blood Testing Picture
Figure 2. Global Oncology Blood Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncology Blood Testing Market Share by Type: 2024 VS 2031
Figure 4. Blood Protein Testing Features
Figure 5. Tumor Marker Testing Features
Figure 6. Others Features
Figure 7. Global Oncology Blood Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Oncology Blood Testing Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Oncology Blood Testing Report Years Considered
Figure 13. Global Oncology Blood Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Oncology Blood Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Oncology Blood Testing Market Share by Region: 2024 VS 2031
Figure 16. Global Oncology Blood Testing Market Share by Players in 2024
Figure 17. Global Top Oncology Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Blood Testing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Oncology Blood Testing Revenue in 2024
Figure 19. North America Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Oncology Blood Testing Market Share by Country (2020-2031)
Figure 21. United States Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oncology Blood Testing Market Share by Country (2020-2031)
Figure 25. Germany Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oncology Blood Testing Market Share by Region (2020-2031)
Figure 33. China Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oncology Blood Testing Market Share by Country (2020-2031)
Figure 41. Mexico Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oncology Blood Testing Market Share by Country (2020-2031)
Figure 45. Turkey Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Guardant Health Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 49. Trovagene Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 50. Genomic Health Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 52. Bio-Techne Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 53. Pathway Genomics Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Oncology Blood Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Protein Testing
Table 3. Key Players of Tumor Marker Testing
Table 4. Key Players of Others
Table 5. Global Oncology Blood Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oncology Blood Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oncology Blood Testing Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Oncology Blood Testing Market Share by Region (2020-2025)
Table 9. Global Oncology Blood Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Oncology Blood Testing Market Share by Region (2026-2031)
Table 11. Oncology Blood Testing Market Trends
Table 12. Oncology Blood Testing Market Drivers
Table 13. Oncology Blood Testing Market Challenges
Table 14. Oncology Blood Testing Market Restraints
Table 15. Global Oncology Blood Testing Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Oncology Blood Testing Market Share by Players (2020-2025)
Table 17. Global Top Oncology Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Blood Testing as of 2024)
Table 18. Ranking of Global Top Oncology Blood Testing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oncology Blood Testing Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Oncology Blood Testing, Headquarters and Area Served
Table 21. Global Key Players of Oncology Blood Testing, Product and Application
Table 22. Global Key Players of Oncology Blood Testing, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Blood Testing Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Oncology Blood Testing Revenue Market Share by Type (2020-2025)
Table 26. Global Oncology Blood Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Oncology Blood Testing Revenue Market Share by Type (2026-2031)
Table 28. Global Oncology Blood Testing Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Oncology Blood Testing Revenue Market Share by Application (2020-2025)
Table 30. Global Oncology Blood Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Oncology Blood Testing Revenue Market Share by Application (2026-2031)
Table 32. North America Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Oncology Blood Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Oncology Blood Testing Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oncology Blood Testing Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Oncology Blood Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Oncology Blood Testing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Oncology Blood Testing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Guardant Health Company Details
Table 48. Guardant Health Business Overview
Table 49. Guardant Health Oncology Blood Testing Product
Table 50. Guardant Health Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 51. Guardant Health Recent Development
Table 52. Trovagene Company Details
Table 53. Trovagene Business Overview
Table 54. Trovagene Oncology Blood Testing Product
Table 55. Trovagene Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 56. Trovagene Recent Development
Table 57. Genomic Health Company Details
Table 58. Genomic Health Business Overview
Table 59. Genomic Health Oncology Blood Testing Product
Table 60. Genomic Health Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 61. Genomic Health Recent Development
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Oncology Blood Testing Product
Table 65. Roche Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Bio-Techne Company Details
Table 68. Bio-Techne Business Overview
Table 69. Bio-Techne Oncology Blood Testing Product
Table 70. Bio-Techne Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 71. Bio-Techne Recent Development
Table 72. Pathway Genomics Company Details
Table 73. Pathway Genomics Business Overview
Table 74. Pathway Genomics Oncology Blood Testing Product
Table 75. Pathway Genomics Revenue in Oncology Blood Testing Business (2020-2025) & (US$ Million)
Table 76. Pathway Genomics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Oncology Blood Testing Picture
Figure 2. Global Oncology Blood Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncology Blood Testing Market Share by Type: 2024 VS 2031
Figure 4. Blood Protein Testing Features
Figure 5. Tumor Marker Testing Features
Figure 6. Others Features
Figure 7. Global Oncology Blood Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Oncology Blood Testing Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Oncology Blood Testing Report Years Considered
Figure 13. Global Oncology Blood Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Oncology Blood Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Oncology Blood Testing Market Share by Region: 2024 VS 2031
Figure 16. Global Oncology Blood Testing Market Share by Players in 2024
Figure 17. Global Top Oncology Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Blood Testing as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Oncology Blood Testing Revenue in 2024
Figure 19. North America Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Oncology Blood Testing Market Share by Country (2020-2031)
Figure 21. United States Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oncology Blood Testing Market Share by Country (2020-2031)
Figure 25. Germany Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oncology Blood Testing Market Share by Region (2020-2031)
Figure 33. China Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oncology Blood Testing Market Share by Country (2020-2031)
Figure 41. Mexico Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oncology Blood Testing Market Share by Country (2020-2031)
Figure 45. Turkey Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Oncology Blood Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Guardant Health Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 49. Trovagene Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 50. Genomic Health Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 52. Bio-Techne Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 53. Pathway Genomics Revenue Growth Rate in Oncology Blood Testing Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232